{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,22]],"date-time":"2026-04-22T12:19:49Z","timestamp":1776860389262,"version":"3.51.2"},"reference-count":46,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2024,8,2]],"date-time":"2024-08-02T00:00:00Z","timestamp":1722556800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2024,8,2]],"date-time":"2024-08-02T00:00:00Z","timestamp":1722556800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"DOI":"10.13039\/501100001809","name":"the National Natural Science Foundation of China","doi-asserted-by":"crossref","award":["8220103844"],"award-info":[{"award-number":["8220103844"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Cancer"],"DOI":"10.1186\/s12885-024-12712-w","type":"journal-article","created":{"date-parts":[[2024,8,2]],"date-time":"2024-08-02T15:04:02Z","timestamp":1722611042000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":2,"title":["Results from a real-world study: a novel glycosyltransferase risk score for prognosis, tumor microenvironment phenotypes and immunotherapy in bladder cancer"],"prefix":"10.1186","volume":"24","author":[{"given":"Renyu","family":"Liu","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ting","family":"Yang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jinyu","family":"Huang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Zicheng","family":"Xiao","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jinhui","family":"Liu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Zhenghao","family":"Li","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shiyu","family":"Tong","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2024,8,2]]},"reference":[{"issue":"3","key":"12712_CR1","doi-asserted-by":"publisher","first-page":"209","DOI":"10.3322\/caac.21660","volume":"71","author":"H Sung","year":"2021","unstructured":"Sung H, Ferlay J, Siegel RL, Laversanne M, Soerjomataram I, Jemal A, Bray F. Global Cancer statistics 2020: GLOBOCAN estimates of incidence and Mortality Worldwide for 36 cancers in 185 countries. Cancer J Clin. 2021;71(3):209\u201349.","journal-title":"Cancer J Clin"},{"issue":"4","key":"12712_CR2","doi-asserted-by":"publisher","first-page":"512","DOI":"10.1007\/s11427-020-1768-y","volume":"64","author":"Z Wu","year":"2021","unstructured":"Wu Z, Liu J, Dai R, Wu S. Current status and future perspectives of immunotherapy in bladder cancer treatment. Sci China Life Sci. 2021;64(4):512\u201333.","journal-title":"Sci China Life Sci"},{"issue":"5","key":"12712_CR3","doi-asserted-by":"publisher","first-page":"404","DOI":"10.3322\/caac.21631","volume":"70","author":"VG Patel","year":"2020","unstructured":"Patel VG, Oh WK, Galsky MD. Treatment of muscle-invasive and advanced bladder cancer in 2020. Cancer J Clin. 2020;70(5):404\u201323.","journal-title":"Cancer J Clin"},{"issue":"1","key":"12712_CR4","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1093\/glycob\/cww086","volume":"27","author":"A Varki","year":"2017","unstructured":"Varki A. Biological roles of glycans. Glycobiology. 2017;27(1):3\u201349.","journal-title":"Glycobiology"},{"issue":"2","key":"12712_CR5","doi-asserted-by":"publisher","first-page":"670","DOI":"10.2741\/3951","volume":"17","author":"F Dall\u2019Olio","year":"2012","unstructured":"Dall\u2019Olio F, Malagolini N, Trinchera M, Chiricolo M. Mechanisms of cancer-associated glycosylation changes. Front Bioscience (Landmark Edition). 2012;17(2):670\u201399.","journal-title":"Front Bioscience (Landmark Edition)"},{"issue":"9","key":"12712_CR6","doi-asserted-by":"publisher","first-page":"540","DOI":"10.1038\/nrc3982","volume":"15","author":"SS Pinho","year":"2015","unstructured":"Pinho SS, Reis CA. Glycosylation in cancer: mechanisms and clinical implications. Nat Rev Cancer. 2015;15(9):540\u201355.","journal-title":"Nat Rev Cancer"},{"issue":"1","key":"12712_CR7","doi-asserted-by":"publisher","first-page":"8485","DOI":"10.1038\/s41598-018-26468-4","volume":"8","author":"LP Fern\u00e1ndez","year":"2018","unstructured":"Fern\u00e1ndez LP, S\u00e1nchez-Mart\u00ednez R, Vargas T, Herranz J, Mart\u00edn-Hern\u00e1ndez R, Mendiola M, Hardisson D, Reglero G, Feliu J, Redondo A, et al. The role of glycosyltransferase enzyme GCNT3 in colon and ovarian cancer prognosis and chemoresistance. Sci Rep. 2018;8(1):8485.","journal-title":"Sci Rep"},{"key":"12712_CR8","doi-asserted-by":"crossref","unstructured":"Fern\u00e1ndez-Ponce C, Geribaldi-Dold\u00e1n N, S\u00e1nchez-Gomar I, Quiroz RN, Ibarra LA, Escorcia LG, Fern\u00e1ndez-Cisnal R, Martinez GA, Garc\u00eda-C\u00f3zar F, Quiroz EN. The role of glycosyltransferases in Colorectal Cancer. Int J Mol Sci 2021, 22(11).","DOI":"10.3390\/ijms22115822"},{"key":"12712_CR9","doi-asserted-by":"publisher","first-page":"12632","DOI":"10.1038\/ncomms12632","volume":"7","author":"CW Li","year":"2016","unstructured":"Li CW, Lim SO, Xia W, Lee HH, Chan LC, Kuo CW, Khoo KH, Chang SS, Cha JH, Kim T, et al. Glycosylation and stabilization of programmed death ligand-1 suppresses T-cell activity. Nat Commun. 2016;7:12632.","journal-title":"Nat Commun"},{"issue":"1","key":"12712_CR10","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s12929-019-0592-z","volume":"27","author":"RM Lu","year":"2020","unstructured":"Lu RM, Hwang YC, Liu IJ, Lee CC, Tsai HZ, Li HJ, Wu HC. Development of therapeutic antibodies for the treatment of diseases. J Biomed Sci. 2020;27(1):1.","journal-title":"J Biomed Sci"},{"key":"12712_CR11","doi-asserted-by":"publisher","first-page":"111","DOI":"10.1016\/bs.ircmb.2018.05.014","volume":"343","author":"AP Cadena","year":"2019","unstructured":"Cadena AP, Cushman TR, Welsh JW. Glycosylation and Antitumor Immunity. Int Rev cell Mol Biology. 2019;343:111\u201327.","journal-title":"Int Rev cell Mol Biology"},{"key":"12712_CR12","doi-asserted-by":"publisher","first-page":"2120","DOI":"10.3389\/fimmu.2019.02120","volume":"10","author":"H L\u00e4ubli","year":"2019","unstructured":"L\u00e4ubli H, Borsig L. Altered cell adhesion and glycosylation promote Cancer Immune suppression and metastasis. Front Immunol. 2019;10:2120.","journal-title":"Front Immunol"},{"key":"12712_CR13","doi-asserted-by":"publisher","first-page":"800967","DOI":"10.3389\/fcell.2021.800967","volume":"9","author":"H Li","year":"2021","unstructured":"Li H, Liu S, Li C, Xiao Z, Hu J, Zhao C. TNF family-based signature predicts prognosis, Tumor Microenvironment, and molecular subtypes in bladder carcinoma. Front cell Dev Biology. 2021;9:800967.","journal-title":"Front cell Dev Biology"},{"key":"12712_CR14","doi-asserted-by":"crossref","unstructured":"Li H, Chen J, Li Z, Chen M, Ou Z, Mo M, Wang R, Tong S, Liu P, Cai Z et al. S100A5 Attenuates Efficiency of Anti-PD-L1\/PD-1 Immunotherapy by Inhibiting CD8(+) T Cell-Mediated Anti-Cancer Immunity in Bladder Carcinoma. Advanced science (Weinheim, Baden-Wurttemberg, Germany) 2023:e2300110.","DOI":"10.1002\/advs.202300110"},{"key":"12712_CR15","doi-asserted-by":"publisher","first-page":"26451","DOI":"10.1038\/srep26451","volume":"6","author":"J Ashkani","year":"2016","unstructured":"Ashkani J, Naidoo KJ. Glycosyltransferase gene expression profiles classify Cancer types and propose prognostic subtypes. Sci Rep. 2016;6:26451.","journal-title":"Sci Rep"},{"issue":"6","key":"12712_CR16","doi-asserted-by":"publisher","first-page":"417","DOI":"10.1016\/j.cels.2015.12.004","volume":"1","author":"A Liberzon","year":"2015","unstructured":"Liberzon A, Birger C, Thorvaldsd\u00f3ttir H, Ghandi M, Mesirov JP, Tamayo P. The Molecular signatures database (MSigDB) hallmark gene set collection. Cell Syst. 2015;1(6):417\u201325.","journal-title":"Cell Syst"},{"issue":"6","key":"12712_CR17","doi-asserted-by":"publisher","first-page":"909","DOI":"10.1038\/s41591-020-0839-y","volume":"26","author":"DA Braun","year":"2020","unstructured":"Braun DA, Hou Y, Bakouny Z, Ficial M, Sant\u2019 Angelo M, Forman J, Ross-Macdonald P, Berger AC, Jegede OA, Elagina L, et al. Interplay of somatic alterations and immune infiltration modulates response to PD-1 blockade in advanced clear cell renal cell carcinoma. Nat Med. 2020;26(6):909\u201318.","journal-title":"Nat Med"},{"issue":"10","key":"12712_CR18","doi-asserted-by":"publisher","first-page":"1545","DOI":"10.1038\/s41591-018-0157-9","volume":"24","author":"N Auslander","year":"2018","unstructured":"Auslander N, Zhang G, Lee JS, Frederick DT, Miao B, Moll T, Tian T, Wei Z, Madan S, Sullivan RJ, et al. Robust prediction of response to immune checkpoint blockade therapy in metastatic melanoma. Nat Med. 2018;24(10):1545\u20139.","journal-title":"Nat Med"},{"issue":"7693","key":"12712_CR19","doi-asserted-by":"publisher","first-page":"544","DOI":"10.1038\/nature25501","volume":"554","author":"S Mariathasan","year":"2018","unstructured":"Mariathasan S, Turley SJ, Nickles D, Castiglioni A, Yuen K, Wang Y, Kadel EE III, Koeppen H, Astarita JL, Cubas R, et al. TGF\u03b2 attenuates tumour response to PD-L1 blockade by contributing to exclusion of T cells. Nature. 2018;554(7693):544\u20138.","journal-title":"Nature"},{"issue":"4","key":"12712_CR20","doi-asserted-by":"publisher","first-page":"420","DOI":"10.1016\/j.eururo.2019.09.006","volume":"77","author":"A Kamoun","year":"2020","unstructured":"Kamoun A, de Reyni\u00e8s A, Allory Y, Sj\u00f6dahl G, Robertson AG, Seiler R, Hoadley KA, Groeneveld CS, Al-Ahmadie H, Choi W, et al. A Consensus Molecular classification of muscle-invasive bladder Cancer. Eur Urol. 2020;77(4):420\u201333.","journal-title":"Eur Urol"},{"issue":"1","key":"12712_CR21","doi-asserted-by":"publisher","first-page":"248","DOI":"10.1016\/j.celrep.2016.12.019","volume":"18","author":"P Charoentong","year":"2017","unstructured":"Charoentong P, Finotello F, Angelova M, Mayer C, Efremova M, Rieder D, Hackl H, Trajanoski Z. Pan-cancer immunogenomic analyses reveal genotype-immunophenotype relationships and predictors of response to checkpoint blockade. Cell Rep. 2017;18(1):248\u201362.","journal-title":"Cell Rep"},{"issue":"19","key":"12712_CR22","doi-asserted-by":"publisher","first-page":"1980","DOI":"10.1001\/jama.2020.17598","volume":"324","author":"AT Lenis","year":"2020","unstructured":"Lenis AT, Lec PM, Chamie K, Mshs MD. Bladder Cancer: a review. JAMA. 2020;324(19):1980\u201391.","journal-title":"JAMA"},{"issue":"1","key":"12712_CR23","doi-asserted-by":"publisher","first-page":"7543","DOI":"10.1038\/s41598-018-26002-6","volume":"8","author":"P Ge","year":"2018","unstructured":"Ge P, Wang L, Lu M, Mao L, Li W, Wen R, Lin J, Wang J, Chen J. Oncological outcome of primary and secondary muscle-invasive bladder Cancer: a systematic review and Meta-analysis. Sci Rep. 2018;8(1):7543.","journal-title":"Sci Rep"},{"issue":"2","key":"12712_CR24","doi-asserted-by":"publisher","first-page":"231","DOI":"10.1016\/j.eururo.2018.09.002","volume":"75","author":"EJ Pietzak","year":"2019","unstructured":"Pietzak EJ, Zabor EC, Bagrodia A, Armenia J, Hu W, Zehir A, Funt S, Audenet F, Barron D, Maamouri N, et al. Genomic differences between primary and secondary muscle-invasive bladder Cancer as a basis for disparate outcomes to cisplatin-based Neoadjuvant Chemotherapy. Eur Urol. 2019;75(2):231\u20139.","journal-title":"Eur Urol"},{"issue":"Pt 2","key":"12712_CR25","doi-asserted-by":"publisher","first-page":"477","DOI":"10.1016\/j.semcancer.2022.06.005","volume":"86","author":"A Indini","year":"2022","unstructured":"Indini A, Massi D, Pirro M, Roila F, Grossi F, Sahebkar A, Glodde N, Bald T, Mandal\u00e0 M. Targeting inflamed and non-inflamed melanomas: biological background and clinical challenges. Sem Cancer Biol. 2022;86(Pt 2):477\u201390.","journal-title":"Sem Cancer Biol"},{"issue":"7","key":"12712_CR26","doi-asserted-by":"publisher","first-page":"605","DOI":"10.1016\/j.trecan.2020.02.022","volume":"6","author":"Q Duan","year":"2020","unstructured":"Duan Q, Zhang H, Zheng J, Zhang L. Turning Cold into Hot: firing up the Tumor Microenvironment. Trends cancer. 2020;6(7):605\u201318.","journal-title":"Trends cancer"},{"issue":"1","key":"12712_CR27","doi-asserted-by":"publisher","first-page":"228","DOI":"10.1186\/s13046-022-02438-7","volume":"41","author":"Z Tan","year":"2022","unstructured":"Tan Z, Jiang Y, Liang L, Wu J, Cao L, Zhou X, Song Z, Ye Z, Zhao Z, Feng H, et al. Dysregulation and prometastatic function of glycosyltransferase C1GALT1 modulated by cHP1BP3\/ mir-1-3p axis in bladder cancer. J Experimental Clin cancer Research: CR. 2022;41(1):228.","journal-title":"J Experimental Clin cancer Research: CR"},{"issue":"2","key":"12712_CR28","doi-asserted-by":"publisher","first-page":"167","DOI":"10.1158\/2326-6066.CIR-19-0514","volume":"8","author":"M Kvorjak","year":"2020","unstructured":"Kvorjak M, Ahmed Y, Miller ML, Sriram R, Coronnello C, Hashash JG, Hartman DJ, Telmer CA, Miskov-Zivanov N, Finn OJ, et al. Cross-talk between Colon Cells and macrophages increases ST6GALNAC1 and MUC1-sTn expression in Ulcerative Colitis and Colitis-Associated Colon cancer. Cancer Immunol Res. 2020;8(2):167\u201378.","journal-title":"Cancer Immunol Res"},{"key":"12712_CR29","doi-asserted-by":"crossref","unstructured":"Xu Y, Gao Z, Hu R, Wang Y, Wang Y, Su Z, Zhang X, Yang J, Mei M, Ren Y et al. PD-L2 glycosylation promotes immune evasion and predicts anti-EGFR efficacy. J Immunother Cancer 2021, 9(10).","DOI":"10.1136\/jitc-2021-002699"},{"key":"12712_CR30","doi-asserted-by":"crossref","unstructured":"Qi Y, Lv W, Liu X, Wang Q, Xing B, Jiang Q, Wang Z, Huang Y, Shu K, Lei T. Comprehensive Analysis Identified Glycosyltransferase Signature to Predict Glioma Prognosis and TAM Phenotype. BioMed research international 2023;2023:6082635.","DOI":"10.1155\/2023\/6082635"},{"key":"12712_CR31","doi-asserted-by":"publisher","first-page":"107164","DOI":"10.1016\/j.compbiomed.2023.107164","volume":"163","author":"J Wu","year":"2023","unstructured":"Wu J, Zhou X, Ren J, Zhang Z, Ju H, Diao X, Jiang S, Zhang J. Glycosyltransferase-related prognostic and diagnostic biomarkers of uterine corpus endometrial carcinoma. Comput Biol Med. 2023;163:107164.","journal-title":"Comput Biol Med"},{"key":"12712_CR32","doi-asserted-by":"publisher","first-page":"856671","DOI":"10.3389\/fgene.2022.856671","volume":"13","author":"H Wu","year":"2022","unstructured":"Wu H, Zhao X, Zhu T, Rong D, Wang Y, Leng D, Wu D. A glycosyltransferase-related signature for Predicting overall survival in Head and Neck squamous cell carcinoma. Front Genet. 2022;13:856671.","journal-title":"Front Genet"},{"key":"12712_CR33","doi-asserted-by":"publisher","first-page":"950783","DOI":"10.3389\/fonc.2022.950783","volume":"12","author":"C Bian","year":"2022","unstructured":"Bian C, Sun X, Huang J, Zhang W, Mu G, Wei K, Chen L, Xia Y, Wang J. A novel glycosyltransferase-related lncRNA signature correlates with lung adenocarcinoma prognosis. Front Oncol. 2022;12:950783.","journal-title":"Front Oncol"},{"issue":"1","key":"12712_CR34","doi-asserted-by":"publisher","first-page":"149","DOI":"10.1186\/s13046-021-01932-8","volume":"40","author":"X Sun","year":"2021","unstructured":"Sun X, He Z, Guo L, Wang C, Lin C, Ye L, Wang X, Li Y, Yang M, Liu S, et al. ALG3 contributes to stemness and radioresistance through regulating glycosylation of TGF-\u03b2 receptor II in breast cancer. J Experimental Clin cancer Research: CR. 2021;40(1):149.","journal-title":"J Experimental Clin cancer Research: CR"},{"key":"12712_CR35","doi-asserted-by":"crossref","unstructured":"Cui X, Pei X, Wang H, Feng P, Qin H, Liu S, Yan Q, Liu J. ALG3 Promotes Peritoneal Metastasis of Ovarian Cancer through Increasing Interaction of \u03b11,3-mannosylated uPAR and ADAM8. Cells 2022;11(19).","DOI":"10.3390\/cells11193141"},{"issue":"3","key":"12712_CR36","doi-asserted-by":"publisher","first-page":"152761","DOI":"10.1016\/j.prp.2019.152761","volume":"216","author":"SB Ke","year":"2020","unstructured":"Ke SB, Qiu H, Chen JM, Shi W, Han C, Gong Y, Chen YS. ALG3 contributes to the malignancy of non-small cell lung cancer and is negatively regulated by MiR-98-5p. Pathol Res Pract. 2020;216(3):152761.","journal-title":"Pathol Res Pract"},{"key":"12712_CR37","doi-asserted-by":"publisher","first-page":"816102","DOI":"10.3389\/fmolb.2022.816102","volume":"9","author":"Z Zhao","year":"2022","unstructured":"Zhao Z, Zheng Z, Huang J, Wang J, Peng T, Lin Y, Jian Z. Expression of ALG3 in Hepatocellular Carcinoma and its clinical implication. Front Mol Biosci. 2022;9:816102.","journal-title":"Front Mol Biosci"},{"issue":"2","key":"12712_CR38","doi-asserted-by":"publisher","first-page":"187","DOI":"10.1016\/j.ccell.2018.01.009","volume":"33","author":"CW Li","year":"2018","unstructured":"Li CW, Lim SO, Chung EM, Kim YS, Park AH, Yao J, Cha JH, Xia W, Chan LC, Kim T, et al. Eradication of Triple-negative breast Cancer cells by targeting glycosylated PD-L1. Cancer Cell. 2018;33(2):187\u2013e201110.","journal-title":"Cancer Cell"},{"issue":"1","key":"12712_CR39","doi-asserted-by":"publisher","first-page":"203","DOI":"10.7150\/thno.88550","volume":"14","author":"D Tang","year":"2024","unstructured":"Tang D, Yan Y, Li Y, Li Y, Tian J, Yang L, Ding H, Bashir G, Zhou H, Ding Q, et al. Targeting DAD1 gene with CRISPR-Cas9 system transmucosally delivered by fluorinated polylysine nanoparticles for bladder cancer intravesical gene therapy. Theranostics. 2024;14(1):203\u201319.","journal-title":"Theranostics"},{"key":"12712_CR40","doi-asserted-by":"crossref","unstructured":"Yang M, Li Y, Kong L, Huang S, He L, Liu P, Mo S, Lu X, Lin X, Xiao Y et al. Inhibition of DPAGT1 suppresses HER2 shedding and trastuzumab resistance in human breast cancer. J Clin Investig 2023, 133(14).","DOI":"10.1172\/JCI164428"},{"issue":"14","key":"12712_CR41","doi-asserted-by":"publisher","first-page":"5673","DOI":"10.1158\/0008-5472.CAN-08-4512","volume":"69","author":"M Nita-Lazar","year":"2009","unstructured":"Nita-Lazar M, Noonan V, Rebustini I, Walker J, Menko AS, Kukuruzinska MA. Overexpression of DPAGT1 leads to aberrant N-glycosylation of E-cadherin and cellular discohesion in oral cancer. Cancer Res. 2009;69(14):5673\u201380.","journal-title":"Cancer Res"},{"issue":"4","key":"12712_CR42","doi-asserted-by":"publisher","first-page":"1120","DOI":"10.1053\/j.gastro.2016.12.036","volume":"153","author":"ZH Chen","year":"2017","unstructured":"Chen ZH, Yu YP, Tao J, Liu S, Tseng G, Nalesnik M, Hamilton R, Bhargava R, Nelson JB, Pennathur A, et al. MAN2A1-FER Fusion Gene is expressed by Human Liver and other Tumor types and has oncogenic activity in mice. Gastroenterology. 2017;153(4):1120\u2013e11321115.","journal-title":"Gastroenterology"},{"issue":"10","key":"12712_CR43","doi-asserted-by":"publisher","first-page":"1207","DOI":"10.1016\/j.ccell.2022.08.012","volume":"40","author":"Q Shi","year":"2022","unstructured":"Shi Q, Shen Q, Liu Y, Shi Y, Huang W, Wang X, Li Z, Chai Y, Wang H, Hu X, et al. Increased glucose metabolism in TAMs fuels O-GlcNAcylation of lysosomal cathepsin B to promote cancer metastasis and chemoresistance. Cancer Cell. 2022;40(10):1207\u2013e12221210.","journal-title":"Cancer Cell"},{"issue":"19","key":"12712_CR44","doi-asserted-by":"publisher","first-page":"5200","DOI":"10.7150\/thno.27806","volume":"8","author":"F Zhou","year":"2018","unstructured":"Zhou F, Yang X, Zhao H, Liu Y, Feng Y, An R, Lv X, Li J, Chen B. Down-regulation of OGT promotes cisplatin resistance by inducing autophagy in ovarian cancer. Theranostics. 2018;8(19):5200\u201312.","journal-title":"Theranostics"},{"key":"12712_CR45","doi-asserted-by":"crossref","unstructured":"van der Haar \u00c0vila I, Zhang T, Lorrain V, de Bruin F, Spreij T, Nakayama H, Iwabuchi K, Garc\u00eda-Vallejo JJ, Wuhrer M, van Kooyk Y et al. Limited impact of cancer-derived gangliosides on anti-tumor immunity in colorectal cancer. Glycobiology 2024, 34(7).","DOI":"10.1093\/glycob\/cwae036"},{"key":"12712_CR46","doi-asserted-by":"publisher","first-page":"115","DOI":"10.1016\/j.gene.2019.05.025","volume":"706","author":"ML Shen","year":"2019","unstructured":"Shen ML, Xiao A, Yin SJ, Wang P, Lin XQ, Yu CB, He GH. Associations between UGT2B7 polymorphisms and cancer susceptibility: a meta-analysis. Gene. 2019;706:115\u201323.","journal-title":"Gene"}],"container-title":["BMC Cancer"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12885-024-12712-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12885-024-12712-w\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12885-024-12712-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,8,2]],"date-time":"2024-08-02T15:04:49Z","timestamp":1722611089000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmccancer.biomedcentral.com\/articles\/10.1186\/s12885-024-12712-w"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,8,2]]},"references-count":46,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2024,12]]}},"alternative-id":["12712"],"URL":"https:\/\/doi.org\/10.1186\/s12885-024-12712-w","relation":{},"ISSN":["1471-2407"],"issn-type":[{"value":"1471-2407","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,8,2]]},"assertion":[{"value":"17 October 2023","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"26 July 2024","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"2 August 2024","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"This study was approved by the Ethics Committee of the Xiangya Hospital of Central South University. The authors are accountable for all aspects of the work in ensuring that questions related to the accuracy or integrity of any part of the work are appropriately investigated and resolved.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Written informed consent for publication was obtained from all participants.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"947"}}